Dr Arner on the Role of SETD2 Loss in Tumor Growth and Metastasis in ccRCC

Emily Arner, PhD, discusses research on the role of SETD2 loss in metastatic clear cell renal cell carcinoma ccRCC.

Related Keywords

Emily Arner ,Vanderbilt University Medical Center ,Division Of Hematology Oncology ,Onclive ,Nccrcc ,Setd2 ,Renal Cell Carcinoma ,Tumor Microenvironment ,Mouse Model ,